IPP Bureau
JB Pharma witness 20% growth in August 2022: IQVIA
By IPP Bureau - September 22, 2022
Our strategy to drive therapy and brand-focused expansion will continue to show results, especially in the domestic business.
Aster Hospitals Bangalore launches 'Aster International Institute of Oncology'
By IPP Bureau - September 22, 2022
This newly launched institute will be the centre of excellence in the treatment of all cancers under a single roof.
BridgeBio Pharma, Sentynl Therapeutics receive marketing authorization in the EU for fosdenopterin
By IPP Bureau - September 22, 2022
NULIBRY is a first-in-class cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A.
Aster Pharmacy forays into Bangladesh
By IPP Bureau - September 22, 2022
Aster Pharmacy will be operated by GD Assist Limited in Bangladesh.
Reasons for the surge in M& A in healthcare and pharmaceutical sectors in India: Ankit Poddar & Navroz Mahudawala, Candle Partners
By IPP Bureau - September 22, 2022
Witnessing sizable consolidation (M& A) activity with Domestic Formulations and Hospitals being two areas wherein maximum M&A has occurred.
Zydus launches Lenalidomide Capsules
By IPP Bureau - September 22, 2022
Lenalidomide is used to treat various types of cancers.
Shilpa Medicare receives tentative approval for Tenofovir Alafenamide Tablets
By IPP Bureau - September 22, 2022
The ANDA was filed as 'First to File' submission on NCE-1 date.
Merck to initiate new Phase 3 clinical program for treatment of HIV-1 Infection
By IPP Bureau - September 21, 2022
Phase 2 study evaluating an investigational weekly oral combination treatment regimen of islatravir and Gilead Sciences’ lenacapavir to resume with lower dose of islatravir
Azelis expands pharmaceutical offerings with Clariant
By IPP Bureau - September 21, 2022
Azelis’ customers now have access to products including the well-established Polyglykol portfolio, as well as a brand-new range of Motusflex and VitiPure excipients.
Medical devices market in Singapore to reach $3.5 billion in 2022, forecasts GlobalData
By IPP Bureau - September 21, 2022
Singapore presents great opportunities for the adoption of technology in healthcare and is open for investments
DAMAN enters ambitious European precision medicine healthcare project
By IPP Bureau - September 21, 2022
Coordinated by the Medical University of Vienna, a consortium of 13 leading European organizations including university hospitals, research institutions and healthcare companies will conduct the 5-year project co-funded by Horizon Europe.
NATCO gets CTPR launch approval from Delhi High Court
By IPP Bureau - September 21, 2022
NATCO is the first company in India to have received its registration approval given by Central Insecticide Board & Registration Committee (CIB&RC) for indigenous manufacture of Chlorantraniliprole
Tezspire approved in the EU for the treatment of severe asthma
By IPP Bureau - September 21, 2022
First and only biologic approved in the EU in patients with severe asthma with no phenotype or biomarker limitations
Evusheld long-acting antibody combination approved in the EU for the treatment of COVID-19
By IPP Bureau - September 21, 2022
Evusheld significantly reduced risk of severe COVID-19 or death in TACKLE Phase III treatment trial
Dolomite Bio launches an affordable microfluidic system for custom protocol development
By IPP Bureau - September 21, 2022
Dolomite Bio scientist demonstrating pipetting into the Nadia Go
